Interview at #AACR15 with Doug Sharp, Colorectal Cancer Advocate
This is my interview at the AACR Annual Meeting with Doug Sharp, Colorectal Cancer Advocate with the O'Sullivan Foundation in Kansas City, Missouri.
Author: cancerassassin1
Added: 04/21/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 21, 2015 Category: Cancer & Oncology Source Type: podcasts
No Adjuvant Oxaliplatin for Elderly CRC Patients
Consensus guidelines offer distinct recommendations for adjuvant and palliative treatments in elderly patients with colorectal cancer, as discussed by Dr David Kerr. (Source: Medscape Oncology)
Source: Medscape Oncology - April 15, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Mechanisms of Angiogenesis Inhibitors in Metastatic Colorectal Cancer
In the first e-learning activity on this 4-part series, Dr. Eric Van Cutsem explains the process of tumor angiogenesis, the biology of the vascular endothelial growth factor (VEGF) ligand/receptor sys...
Author: imedex
Added: 04/07/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 7, 2015 Category: Cancer & Oncology Source Type: podcasts
Are Colon Cancer Rates Increasing in Young Adults?
Dr. William Grady, Medical Director of the GI Cancer Prevention Program at Seattle Cancer Care Alliance, discusses factors for preventing colon cancer and the rise of colon cancer in young adults. Dr....
Author: patientpower
Added: 03/31/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2015 Category: Cancer & Oncology Source Type: podcasts
Efficacy of post-PCI dual antiplatelet therapy by stent type, concordance in breast biopsy readings, NSAIDs and colorectal cancer risk, early imaging for uncomplicated back pain, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 17, 2015 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 17, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Targeting Colorectal Cancer: KRAS and NRAS Mutations
At the European Society for Medical Oncology (ESMO) 2014 Congress, Heinz-Josef Lenz, M.D., (USC Norris Cancer Center) discusses the importance of improved technologies in identifying KRAS and NRAS mut...
Author: vitaloptions
Added: 03/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 13, 2015 Category: Cancer & Oncology Source Type: podcasts
Targeting Colon Cancer: Hope for Metastatic Colorectal Cancer Patients
At the European Society for Medical Oncology (ESMO) 2014 Congress, Johanna Bendell, M.D., (Sarah Cannon Research Institute) discusses hope in a new chemotherapy pill for refractory colorectal cancer a...
Author: vitaloptions
Added: 03/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 13, 2015 Category: Cancer & Oncology Source Type: podcasts
Targeting Colon Cancer: Toxicities and Side Effects During Treatment
At the European Society for Medical Oncology (ESMO) 2014 Congress, Johanna Bendell, M.D. (Sarah Cannon Research Institute), discusses patient choice in the selection of a chemotherapy regimen for colo...
Author: vitaloptions
Added: 03/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 12, 2015 Category: Cancer & Oncology Source Type: podcasts
Colon cancer challenge foundation
3/9/2015 —In this episode, we talk with Dr. Thomas Weber (President, Colon Cancer Challenge Foundation) and Katie Rich about the Colon Cancer Challenge Foundation and the first ever early age onset/young adult colorectal cancer summit. Survivor Spotlight on international motivational speaker and public health advocate Jessica Melore (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - March 10, 2015 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
CRC Survival Goes Down in Smoke
Prompted by a recent study on the effects of smoking on colorectal cancer survival, Dr David Kerr reports that he has increased his efforts to get his patients to stop smoking. (Source: Medscape Oncology)
Source: Medscape Oncology - March 9, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
KRAS/NRAS Mutations in mCRC discussion with Dr. Peeters
Dr. Peeters discusses an analysis of RAS mutations in the phase III study 20050181, which compared panitumumab plus FOLFIRI versus FOLFIRI for second-line treatment of metastatic colorectal cancer (mC...
Author: feeds
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr. Kozloff Discusses Validation of The Oncotype DX
An overview with Dr. Mark Kozloff of the independent validation process for the Oncotype DX Colon Cancer test.
Author: feeds
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
What is the Oncotype DX Colon Cancer Test?
Kelly Shimabukuro discusses how doctors use this new test in this short video. Learn why doctors are using the Oncotype DX tests more and more.This new diagnostic tool is helping doctors better quanti...
Author: feeds
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
mCRC Treatment Goals Newly Diagnosed
In newly diagnosed patients with metastatic colorectal cancer.Marwan G. Fakih, MD, discusses the importance of RAS testing at diagnosis and important factors to determine the goals of therapy in newly...
Author: onclivetv
Added: 02/24/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2015 Category: Cancer & Oncology Source Type: podcasts
